Better screening saves lives.® ViziLite® Plus with TBlue® is the leading oral cancer screening system that was developed to help oral healthcare professionals identify, evaluate, monitor and mark abnormal oral lesions suspicious for pathology including precancerous cells and cancer that may be difficult to see during a regular visual exam.

ViziLite® Plus with TBlue® Advantage:

• Patented and clinically proven technology that has been helping healthcare professionals for more than a decade¹
• A clinical study has shown that the use of ViziLite® Plus with TBlue® after a conventional visual examination resulted in:¹

— NO FALSE NEGATIVE OUTCOMES, meaning in this clinical study ViziLite® Plus with TBlue® identified every lesion that had precancerous cells or cancer¹

— SIGNIFICANTLY REDUCING the number of false positive lesions identified during standard visual examinations – limiting the number of biopsies that may have normally been performed¹

• Quick and easy-to-use system that incorporates seamlessly into your existing oral cancer screening examination
• Small device makes it easy to see all areas of the oral cavity
• Disposable technology eliminates cross-contamination
• TBlue® is manufactured in a GMP facility, providing consistency in product quality

ViziLite® Plus with TBlue® "No Regrets" Promise:

• NO costly capital investment
• NO technology obsolescence and support limitations as next generation products are introduced
• NO claims without supporting clinical studies
• NO limitations when viewing oral cavity due to size of device

Squamous cell carcinoma

ViziLite® Plus with TBlue® package insert